Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase EARLY_PHASE1 1Phase 2/3 1Phase 2 1

Status

Recruiting 3Terminated 2Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Dermatologic 1Breast 1

Conditions

Recurrence 1Melanoma 1Head and Neck Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 119Specimen Handling 104pembrolizumab 102Magnetic Resonance Spectroscopy 96fludarabine 92Biopsy 79Injections 53Nivolumab 41venetoclax 40Bevacizumab 40Fluorouracil 38Paclitaxel 37Cisplatin 36Cetuximab 35Carboplatin 35Gemcitabine 31fludarabine phosphate 30Radiotherapy 30Oxaliplatin 30Leucovorin 28Immunotherapy, Adoptive 25Drug Therapy 25Ipilimumab 24Azacitidine 23Irinotecan 21130-nm albumin-bound paclitaxel 21tislelizumab 20Temozolomide 20Radiation 20atezolizumab 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Recruiting × perflutren × Clear all
NCT07501650 2026-03-30

Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer

Thomas Jefferson University

Phase 1 Recruiting
6 enrolled
Head & Neck

Head and Neck Neoplasms, Recurrence

NCT06171607 2026-02-02

Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses

University of Southern California

Phase 1 Recruiting
100 enrolled
Breast

Breast Neoplasms

NCT05620290 2023-12-15

MRI-Guided Focused Ultrasound Radiosensitization for Patients With Malignant Melanoma and Non Melanoma Skin Cancer

Sunnybrook Health Sciences Centre

Phase 1 Recruiting
20 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡